IL18 and non-small cell lung carcinoma: High levels of IL-18 were shown to be found in plasmas and tissue of immunotherapy-responding non-small cell lung cancer patients, and were linked to an antitumor immune gene signature [140] and a reduced tumor burden [139,141].